Tahamtan Ahmadi Selected Research

Tahamtan Ahmadi Research Topics

Disease

28	Multiple Myeloma 01/2024 - 11/2010
11	Neoplasms (Cancer) 11/2022 - 11/2010
9	Disease Progression 01/2024 - 10/2016
7	Neutropenia 11/2021 - 08/2016
5	Pneumonia (Pneumonitis) 11/2021 - 11/2010
4	Lymphopenia (Lymphocytopenia) 11/2021 - 01/2019
3	Residual Neoplasm 01/2024 - 10/2016
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2024 - 10/2023
3	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2014
3	Thrombocytopenia (Thrombopenia) 01/2021 - 08/2016
3	Anemia 01/2019 - 08/2016
3	Lymphoma (Lymphomas) 04/2015 - 05/2012
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2023 - 11/2010
2	Heart Failure 01/2021 - 11/2010
2	Immunoglobulin Light-chain Amyloidosis 01/2021 - 05/2012
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021 - 11/2010
2	Body Weight (Weight, Body) 08/2016 - 09/2015
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 04/2015 - 01/2014
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2009 - 02/2009
1	Hypertension (High Blood Pressure) 10/2021
1	Septic Shock (Toxic Shock Syndrome) 10/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Diarrhea 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Amyloidosis 01/2021
1	Infections 01/2017
1	Fatigue 04/2016
1	Autoimmune Diseases (Autoimmune Disease) 03/2016
1	Hematologic Neoplasms (Hematological Malignancy) 03/2016
1	Plasmacytoma 03/2016
1	Myocarditis (Carditis) 11/2010
1	Dermatitis 11/2010
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 11/2010
1	Hypersensitivity (Allergy) 11/2010
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2010
1	Familial Primary Pulmonary Hypertension 07/2006

Drug/Important Bio-Agent (IBA)

26	daratumumabIBA 01/2024 - 06/2015
17	Dexamethasone (Maxidex)FDA LinkGeneric 01/2024 - 11/2010
12	Lenalidomide (CC 5013)FDA Link 01/2024 - 11/2010
8	Monoclonal AntibodiesIBA 01/2018 - 03/2016
7	Bortezomib (Velcade)FDA Link 01/2024 - 08/2016
6	Proteasome InhibitorsIBA 10/2023 - 04/2016
3	Thalidomide (Thalomid)FDA Link 10/2021 - 11/2010
3	Rituximab (Mabthera)FDA Link 04/2015 - 02/2009
2	EpitopesIBA 07/2023 - 03/2016
2	AntibodiesIBA 01/2022 - 03/2016
2	CytokinesIBA 01/2022 - 01/2021
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021 - 02/2009
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 05/2012
2	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2021 - 05/2012
2	pomalidomideIBA 01/2021 - 01/2017
2	Immunoglobulins (Immunoglobulin)IBA 01/2018 - 10/2016
2	Immunomodulating AgentsIBA 11/2016 - 04/2016
2	Proteins (Proteins, Gene)FDA Link 03/2016 - 05/2012
1	Tumor Biomarkers (Tumor Markers)IBA 11/2022
1	AntigensIBA 01/2022
1	cyclopropapyrroloindoleIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	EnzymesIBA 01/2022
1	Cytochrome P-450 CYP1B1IBA 05/2012
1	Peptides (Polypeptides)IBA 05/2012
1	VaccinesIBA 05/2012
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 05/2012
1	Combined VaccinesIBA 05/2012
1	fludarabineIBA 02/2009
1	Imatinib Mesylate (Gleevec)FDA Link 07/2006

Therapy/Procedure

18	Therapeutics 01/2024 - 02/2009
3	Stem Cell Transplantation 11/2021 - 01/2019
2	Transplantation 12/2023 - 11/2021
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 11/2021
1	Intravenous Infusions 01/2017